002873 Guiyang Xintian Pharmaceutical
- 11.53
- +0.02+0.17%
Guiyang Xintian Pharmaceutical News
Xintian Pharmaceutical: 002873 Xintian Pharmaceutical performance briefing, roadshow event information 20240419
Xintian Pharmaceutical: Announcement on Further Explanation of the 2023 Profit Distribution Plan
Xintian Pharmaceutical: 002873 Xintian Pharmaceutical Research Activity Information 20240416
Xintian Pharmaceutical: Review Opinions of the 2nd Special Meeting of Independent Directors of the 7th Board of Directors
Xintian Pharmaceutical: Comparative Table of Amendments to the Articles of Association
Xintian Pharmaceutical: Huachuang Securities Co., Ltd.'s inspection opinions on the storage and use of funds raised by the company in 2023
Xintian Pharmaceutical: Report of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties by the Audit Committee
Xintian Pharmaceutical: Special Instructions on the Use of Annual Funds Raised
Xintian Pharmaceutical: Special opinion of the board of directors on the evaluation of the independence of independent directors
Xintian Pharmaceutical: Notice on the repurchase and cancellation of some restricted stocks that have been granted but the sales restrictions have not yet been lifted
Xintian Pharmaceutical: 2023 Annual Debriefing Report of Independent Directors (Zhang Jie)
Xintian Pharmaceutical: 2023 Annual Report
Xintian Pharmaceutical: Internal Control Audit Report
Xintian Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
Xintian Pharmaceutical: Announcement on Hiring a 2024 Financial and Internal Control Auditor
Xintian Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Xintian Pharmaceutical: 2023 Annual Report Summary
Xintian Pharmaceutical: Report on the Work of the Board of Directors in 2023
Xintian Pharmaceutical: 2023 Annual Debriefing Report of Independent Directors (Gao Lijin)
Xintian Pharmaceutical: 2023 Annual Audit Report
Analysis
Price Target
No Data
